Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AML
Phase 1 & 2 Recruiting
- Stanford University, Palo Alto, California, United States
Trials & centers
Ask your doctor
Recruiting trials
CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Phase 1 Recruiting
- Moffitt Cancer Center, Tampa, Florida, United States
Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial
Phase 2 Recruiting
- UC San Diego Moores Cancer Center, La Jolla, California, United States
- Yale University, New Haven, Connecticut, United States
- Yale-New Haven Hospital North Haven Medical Center, North Haven, Connecticut, United States
- More sites
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Phase 1 Recruiting
- Mayo Clinic - Phoenix, Phoenix, Arizona, United States
- Moores UC San Diego Cancer Center, La Jolla, California, United States
- USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
- More sites
Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
Phase 1 & 2 Recruiting
- Novant Health Cancer Institute, Charlotte, North Carolina, United States
- Novant Health Cancer Institute, Winston-Salem, North Carolina, United States
- MD Anderson Cancer Center, Houston, Texas, United States
Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
Phase 2 Recruiting
- The Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
- Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- More sites
Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
Phase 2 Recruiting
- MD Anderson Cancer Center, Houston, Texas, United States
Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation
Phase 1 Recruiting
- OHSU Knight Cancer Institute, Portland, Oregon, United States
NCI-designated centers
Comprehensive & clinical
Alabama
O'Neal Comprehensive Cancer Center
Birmingham, Alabama
Arizona
Mayo Clinic Cancer Center
Phoenix, Arizona
University of Arizona Cancer Center
Tucson, Arizona
California
City of Hope Comprehensive Cancer Center
Duarte, California
Moores Comprehensive Cancer Center
La Jolla, California
Jonsson Comprehensive Cancer Center
Los Angeles, California
USC Norris Comprehensive Cancer Center
Los Angeles, California
Chao Family Comprehensive Cancer Center
Orange, California
UC Davis Comprehensive Cancer Center
Sacramento, California
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California
Stanford Cancer Institute (SCI)
Stanford, California
Colorado
University of Colorado Cancer Center
Aurora, Colorado
Connecticut
Yale Cancer Center
New Haven, Connecticut
District of Columbia
Georgetown Lombardi Comprehensive Cancer Center
Washington, District of Columbia
Florida
University of Florida Health Cancer Institute
Gainesville, Florida
Mayo Clinic Cancer Center
Jacksonville, Florida
Sylvester Comprehensive Cancer Center
Miami, Florida
Moffitt Cancer Center
Tampa, Florida
Georgia
Winship Cancer Institute
Atlanta, Georgia
Hawai'i
University of Hawai'i Cancer Center
Honolulu, Hawai'i
Illinois
Robert H. Lurie Comprehensive Cancer Center
Chicago, Illinois
The University of Chicago Comprehensive Cancer Center
Chicago, Illinois
Indiana
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis, Indiana
Iowa
Holden Comprehensive Cancer Center
Iowa City, Iowa
Kansas
The University of Kansas Cancer Center
Kansas City, Kansas
Kentucky
Markey Cancer Center
Lexington, Kentucky
Maryland
Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
Baltimore, Maryland
Massachusetts
Dana-Farber/Harvard Cancer Center
Boston, Massachusetts
Michigan
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan
The Barbara Ann Karmanos Cancer Institute
Detroit, Michigan
Minnesota
Masonic Cancer Center
Minneapolis, Minnesota
Mayo Clinic Cancer Center
Rochester, Minnesota
Missouri
Alvin J. Siteman Cancer Center
St. Louis, Missouri
Nebraska
Fred and Pamela Buffett Cancer Center
Omaha, Nebraska
New Hampshire
Dartmouth Cancer Center
Lebanon, New Hampshire
New Jersey
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey
New Mexico
University of New Mexico Cancer Research and Treatment Center
Albuquerque, New Mexico
New York
Montefiore Einstein Cancer Center
Bronx, New York
Roswell Park Comprehensive Cancer Center
Buffalo, New York
Herbert Irving Comprehensive Cancer Center
New York, New York
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health
New York, New York
Memorial Sloan-Kettering Cancer Center
New York, New York
Mount Sinai Tisch Cancer Center
New York, New York
Wilmot Cancer Institute
Rochester, New York
North Carolina
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina
Duke Cancer Institute
Durham, North Carolina
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina
Ohio
Case Comprehensive Cancer Center
Cleveland, Ohio
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio
Oklahoma
Stephenson Cancer Center
Oklahoma City, Oklahoma
Oregon
Knight Cancer Institute
Portland, Oregon
Pennsylvania
Abramson Cancer Center
Philadelphia, Pennsylvania
Fox Chase Cancer Center
Philadelphia, Pennsylvania
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania
South Carolina
Hollings Cancer Center
Charleston, South Carolina
Tennessee
St. Jude Children's Research Hospital
Memphis, Tennessee
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee
Texas
Harold C. Simmons Comprehensive Cancer Center
Dallas, Texas
Dan L Duncan Comprehensive Cancer Center
Houston, Texas
The University of Texas MD Anderson Cancer Center
Houston, Texas
Mays Cancer Center at UT Health San Antonio
San Antonio, Texas
Utah
Huntsman Cancer Institute
Salt Lake City, Utah
Virginia
University of Virginia Cancer Center
Charlottesville, Virginia
VCU Massey Comprehensive Cancer Center
Richmond, Virginia
Washington
Fred Hutchinson/University of Washington/Seattle Children's Cancer Consortium
Seattle, Washington
Wisconsin
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin